Continuous Quality Improvement
Concurrent Education Session - 60 minutes
Oncology care is increasingly shifting from the inpatient setting to the outpatient setting, where more than 600,000 patients with cancer receive outpatient chemotherapy. However, not all outpatient facilities have regular access to infection prevention expertise or dedicated infection prevention policies for patient protection. There is limited federal and state regulatory oversight of outpatient oncology facilities, in spite of the fact that high-risk procedures such as reconstituting and compounding of parenteral medication and infusion to the central vascular system are common practices in these facilities. The speakers will describe a recent outbreak of fungal bloodstream infections associated with nonsterile parenteral medication compounding in a New York City outpatient oncology practice, including the CDC perspective on the magnitude and unusual aspects of the outbreak, the hospital perspective on recognition of the outbreak and the coordinated response with local health department and CDC, and the New York City Department of Health and Mental Hygiene (NYC DOHMH) perspective on the regulatory landscape of infection prevention, including the safe preparation and injection of parenteral medication in outpatient oncology facilities, with emphasis on the NYC DOHMH response to this outbreak.
NYC Department of Health and Mental Hygiene
Montclair, New Jersey
Joel Ackelsberg, MD, an infectious disease physician and CDC-trained medical epidemiologist, is the New York City Department of Health and Mental Hygiene’s bioterrorism surveillance coordinator. He came to the Health Department’s Bureau of Communicable Disease in 2000 to direct its bioterrorism planning efforts. Since then, Dr. Ackelsberg has been closely involved with all New York City efforts to enhance the effective management of incidents involving biological threat agents. He has participated at a leadership level in all Health Department responses to such incidents, including anthrax in 2001 and 2006, SARS, the pandemic influenza, the Ebola virus disease, Legionnaires’ disease outbreaks in 2015 , and the Zika virus.
Lenox Hill Hospital
New York, New York
Sandra Elkind began her career in infection control in 1985 working in a large acute care medical center in New York City. She was first certified in 1987. Her interest in infection control was an outgrowth of clinical work as a registered nurse in cardiothoracic surgery, general surgical ICU, and oncology. She is passionate about worker safety, developed a second specialty in occupational health, and has worked as a director in both areas. She first became certified in occupational health in 2002. She has presented in the media, radio, and print on infection control topics of interest to the public. Her master’s degree is in nursing education and reflects her interest in teaching and mentoring others.
Epidemic Intelligence Service Officer
Centers for Disease Control and Prevention
Amber Vasquez is an infectious diseases physician and epidemiologist working in her second year as an epidemic intelligence service officer at the CDC’s Division of Healthcare Quality Promotion, Prevention and Response Branch.
Thursday, June 15
3:45 PM – 4:45 PM
Lenox Hill Hospital
New York, New York
Janet Haas is the director of epidemiology at Lenox Hill Hospital, as well as an associate editor of the American Journal of Infection Control. She has been involved with the APIC Professional Development and Research Committees and the APIC Board of Directors. She’s the author of many peer-reviewed articles, and has been a reviewer for the American Journal of Infection Control for eight years.
Wednesday, June 14
3:00 PM – 4:00 PM
The asset you are trying to access is locked. Please enter your access key to unlock.